IntroMedic Co., Ltd. Stock

Equities

A150840

KR7150840007

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E. 07:00:00 2022-03-13 pm EDT 5-day change 1st Jan Change
5,850 KRW -4.26% Intraday chart for IntroMedic Co., Ltd. -.--% -.--%
Sales 2022 9.88B 7.18M Sales 2023 10.16B 7.38M Capitalization 224B 163M
Net income 2022 -23.26B -16.91M Net income 2023 -6.82B -4.96M EV / Sales 2022 22.9 x
Net Debt 2022 2.42B 1.76M Net Debt 2023 6.09B 4.43M EV / Sales 2023 22.6 x
P/E ratio 2022
-9.61 x
P/E ratio 2023
-32.9 x
Employees 62
Yield 2022 *
-
Yield 2023
-
Free-Float 88.55%
More Fundamentals * Assessed data
Dynamic Chart
IntroMedic Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
NexOptic Technology Corp. Signs MOU with IntroMedic Co., Ltd CI
IntroMedic Co., Ltd. cancelled the transaction announced on November 29, 2021 CI
IntroMedic Co., Ltd.(KOSDAQ:A150840) dropped from S&P Global BMI Index CI
IntroMedic Co., Ltd. announced that it expects to receive KRW 20 billion in funding CI
IntroMedic Co., Ltd.(KOSDAQ:A150840) added to S&P Global BMI Index CI
IntroMedic Co., Ltd. announced that it has received KRW 16.99999922 billion in funding from AMB 2000DC WON INC. CI
Jae- seong Kim and Ye-seung Lee entered into an agreement to acquire 4.1% stake in IntroMedic Co., Ltd. from Asset Cornerstone Association for KRW 3.2 billion. CI
DSP Corporation completed the acquisition of EMnI Co., Ltd. from Hans Eng Corp. and IntroMedic Co., Ltd.. CI
DSP Corporation entered into an agreement to acquire EMnI Co., Ltd. from Hans Eng Corp. and IntroMedic Co., Ltd. for KRW 3.1 billion. CI
IntroMedic Co., Ltd. announced that it expects to receive KRW 19.99999982 billion in funding from AMB 2000DC WON INC. and another investor CI
IntroMedic Co., Ltd. announced that it has received KRW 4.5 billion in funding from FIT Technology Co., Ltd., and another investor CI
EMnI Co., Ltd. announced that it has received KRW 1.5 billion in funding from IntroMedic Co., Ltd. CI
EMnI Co., Ltd. announced that it expects to receive KRW 1.5 billion in funding from IntroMedic Co., Ltd. CI
IntroMedic Co., Ltd. announced that it expects to receive KRW 6 billion in funding from FIT Technology Co., Ltd. and another investor CI
More news
3 years
2 200.00
Extreme 2200
8 220.00
5 years
1 605.00
Extreme 1605
9 940.00
10 years
1 605.00
Extreme 1605
16 425.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 32 -
Chief Executive Officer 60 -
Director/Board Member 54 -
Members of the board TitleAgeSince
Director/Board Member 60 18-03-29
Chief Executive Officer 60 -
Director/Board Member 59 -
More insiders
IntroMedic Co., Ltd. is a Korea-based company mainly engaged in the development, manufacture and distribution of medical equipment. The Company’s products consist of capsule endoscope, which is used for small intestine check under the brand name MiroCam; disposable endoscope, which is used to detect abnormalities of the esophagus and the stomach under the brand name E.G. Scan, and other accessories, such as abdominal disposable data belts and others. The Company distributes its products within domestic market and to overseas markets.
More about the company
  1. Stock Market
  2. Equities
  3. A150840 Stock